Large-scale genetic study links Irritable Bowel Syndrome and cardiovascular disease Dr. Kamal Kant Kohli24 April 2024 6:30 AM ISTNew research published today in the journal Cellular and Molecular Gastroenterology and Hepatology sheds light on disease mechanisms common to...
Treating gum disease after heart rhythm ablation reduced risk of AFib recurrence: Study Dr. Kamal Kant Kohli23 April 2024 8:15 PM ISTTreating gum disease in the 3-months after a procedure to correct an irregular heartbeat known as atrial fibrillation (AFib) may lower oral...
New study reveals E-cigarette use poses elevated risk of heart failure Medha Baranwal23 April 2024 9:30 AM ISTUSA: People using e-cigarettes are significantly more likely to develop heart failure (HF) compared with those who have never used them. The findings...
Mandibular Advancement Device Matches CPAP for BP Reduction in OSA Patients: Study Dr Riya Dave23 April 2024 9:00 AM ISTResearchers have found in a new study that the mandibular advancement device (MAD) is non-inferior to continuous positive airway pressure (CPAP)...
Unlocking the Link: Elevated Lp(a) Levels and ASCVD Risk in Patients with Diabetes Medha Baranwal22 April 2024 9:30 AM ISTUSA: Higher lipoprotein (a) levels are associated with an increased atherosclerotic cardiovascular disease (ASCVD) risk, including in patients with...
Increase in fasting blood sugar tied to higher risk of silent heart attack: Study Medha Baranwal21 April 2024 8:30 PM ISTUSA: Findings from a pooled analysis of four cohort studies support the significance of routine cardiac screening for subjects with elevated fasting...
Among diabetes patients, SGLT2 inhibitors less likely to cause gout compared to sulfonylureas: JAMA Medha Baranwal20 April 2024 10:00 AM ISTUSA: The use of SGLT2 inhibitors versus sulfonylureas was associated with a lower risk of incident gout, heart failure (HF), and major adverse...
Rivaroxaban Plus Aspirin Shows Favorable Benefit-Risk Profile in PAD Patients after revascularization, suggests study Dr Riya Dave20 April 2024 8:30 AM ISTThe VOYAGER PAD trial evaluated the efficacy and safety of rivaroxaban plus aspirin compared to aspirin alone in patients with symptomatic peripheral...
Antipsychotics for dementia linked to more harms than previously acknowledged: BMJ Dr. Kamal Kant Kohli20 April 2024 3:45 AM ISTAntipsychotic use in people with dementia is associated with elevated risks of a wide range of serious adverse outcomes including stroke, blood clots,...
Infusion of human apolipoprotein A1 fails to reduce cardiovascular events in acute MI patients: NEJM Jacinthlyn Sylvia19 April 2024 9:30 PM ISTA recent international clinical trial by C. Michael Gibson and colleagues investigated the efficacy of CSL112 (human Apolipoprotein A1) which helps in...
Use of Low-Dose Colchicine Safe for Prevention of Coronary artery Disease, new Study Reveals Dr.Niharika Harsha B19 April 2024 8:45 PM ISTIn a recent review, researchers have shed light on the safety profile of low-dose colchicine, offering reassuring evidence for its use in secondary...
Atrial Shunt Devices may Redefine Heart Failure Management: JAMA Medha Baranwal19 April 2024 10:00 AM ISTUSA: Heart failure with preserved ejection fraction (HFpEF) presents a complex clinical challenge, with limited treatment options compared to heart...
